Baosheng Guo
Hong Kong Baptist University(HK)China Pharmaceutical University(CN)National Clinical Research Center for Digestive Diseases(CN)Nanjing Drum Tower Hospital(CN)National Clinical Research(US)Beijing Meteorological Bureau(CN)Shenzhen Institute for Drug Control(CN)Kunshan Industrial Technology Research Institute(CN)Zhejiang University of Technology(CN)Nanjing Medical University(CN)Nanjing University(CN)
Publications by Year
Research Areas
Bone Metabolism and Diseases, MicroRNA in disease regulation, Bone health and treatments, RNA Interference and Gene Delivery, Extracellular vesicles in disease
Most-Cited Works
- → Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation(2016)582 cited
- → miR-214 targets ATF4 to inhibit bone formation(2012)567 cited
- → A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy(2012)403 cited
- → Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy(2015)343 cited
- → METTL3-mediated m6A modification of ATG7 regulates autophagy-GATA4 axis to promote cellular senescence and osteoarthritis progression(2021)341 cited
- → A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer(2017)278 cited